Mistral Pharma Inc.
TSX VENTURE : MIP

Mistral Pharma Inc.

October 03, 2005 11:15 ET

Mistral Pharma to Present at BIOCONTACT 2005

MONTREAL, QUEBEC--(CCNMatthews - Oct. 3, 2005) - Mistral Pharma Inc. (TSX VENTURE:MIP) announced today that it will be a presenter at the BIOCONTACT 2005 conference at the Chateau Frontenac in Quebec. This presentation will be given by Mr. Bertrand Bolduc, President and Chief Executive Officer of Mistral Pharma on October 5, 2005 in the Jacques-Cartier room at 3h30 p.m.

"This is a great opportunity to showcase Mistral Pharma to the investment community and to present our exciting projects and commercial partnership opportunities" commented Mr. Bolduc.

About BioContact 2005

BioContact is a partnership symposium gathering over 1200 participants. More than 150 biopharmaceutical companies, coming from Canada, the United States, Asia and Europe, will be presenting in different sectors of activities (diagnostics, therapeutics, and services) and disciplines: cancer, cardiology, drug delivery systems, endocrinology / virology, genomics / proteomics, immunology / infectiology, neurobiology, medical technologies, services. For more information visit the BioContact website at www.biocontact.qc.ca.

About Mistral Pharma Inc.

Mistral Pharma is an emerging oral drug delivery company which develops generic and branded controlled-delivery products using its PROCISE™, SAVIT™ and CHRONOP™ geometry surface area technologies. These technologies offer many competitive advantages including flexible and fast development, competitive cost of goods and the use of "generally recognized as safe" excipients. Additional information about Mistral Pharma can be obtained on Mistral Pharma's website at www.mistralpharma.com.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this press release.

Contact Information